MedPath

Universitätsklinikum Hamburg-Eppendorf

Universitätsklinikum Hamburg-Eppendorf logo
🇩🇪Germany
Ownership
Subsidiary
Established
1989-05-19
Employees
1K
Market Cap
-
Website
http://www.uke.de

Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory T(11;14) Multiple Myeloma

Phase 1
Recruiting
Conditions
Multiple Myeloma in Relapse
Multiple Myeloma
Interventions
Drug: Belantamab mafodotin, Venetoclax
First Posted Date
2023-05-11
Last Posted Date
2025-03-30
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
45
Registration Number
NCT05853965
Locations
🇩🇪

Klinikum Chemnitz, Chemnitz, Germany

🇩🇪

Uniklinkum Ulm, Ulm, Germany

🇩🇪

Uniklinik Heidelberg, Heidelberg, Germany

and more 2 locations

ADVOS® Versus CVVHD in Metabolic or Mixed Acidosis

Not Applicable
Recruiting
Conditions
Metabolic Acidosis
Interventions
Device: ADVOS
Device: CVVHD
First Posted Date
2023-05-06
Last Posted Date
2023-05-09
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
52
Registration Number
NCT05842369
Locations
🇩🇪

University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Avoiding Postinduction Hypotension: the Clinical ZERO-HYPOTENSION Proof-of-concept Study

Not Applicable
Completed
Conditions
Anesthesia
Hypotension on Induction
Hypotension
Interventions
Procedure: Monitoring
Procedure: Norepinephrine preparation
Procedure: Propofol administration
Procedure: Alarm adjustment
Procedure: Intervention threshold
First Posted Date
2023-05-06
Last Posted Date
2023-09-11
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
120
Registration Number
NCT05842759
Locations
🇩🇪

University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Best End-Expiratory and Driving-pressure for Individualized Flow Controlled Ventilation in Patients With COPD

Completed
Conditions
Anesthesia
COPD
Ventilator Lung
First Posted Date
2023-04-13
Last Posted Date
2024-07-25
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
10
Registration Number
NCT05812365
Locations
🇩🇪

University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Nasotracheal Intubation in Critically Ill.

Not Applicable
Completed
Conditions
Critical Care
Tracheal Intubation Morbidity
Interventions
Device: nasotracheal intubation
Device: orotracheal intubation
First Posted Date
2023-03-22
Last Posted Date
2025-01-14
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
126
Registration Number
NCT05780385
Locations
🇩🇪

Universitätsklinikum Hamburg-Eppendorf, Hamburg, HH, Germany

KTP Laser vs Pulsed Dye Laser for Port-Wine Stains

Not Applicable
Recruiting
Conditions
Port-Wine Stain
Interventions
Device: PDL
Device: KTP
First Posted Date
2023-03-16
Last Posted Date
2023-03-16
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
30
Registration Number
NCT05771311
Locations
🇩🇪

Laser Department, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Potassium Titanyl Phosphate Laser Versus Pulsed Dye Laser for Rosacea - a Prospective Study

Not Applicable
Recruiting
Conditions
Rosacea
Interventions
Device: 532nm KTP
Device: 585nm PDL
First Posted Date
2023-03-16
Last Posted Date
2023-03-16
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
30
Registration Number
NCT05771298
Locations
🇩🇪

Laser Department, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany

A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

Phase 1
Recruiting
Conditions
Chronic Hepatitis B
Interventions
Biological: TherVacB
Biological: HEPLISAV B; TherVacB
First Posted Date
2023-02-14
Last Posted Date
2025-04-24
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
24
Registration Number
NCT05727267
Locations
🇩🇪

Division of Infectious Diseases and Tropical Medicine, LMU Klinikum, Munich, Germany

🇩🇪

Bernhard Nocht Centre for Clinical Trials (BNCCT), Hamburg, Germany

Evaluation of a Communication Skills Training for Nurses

Not Applicable
Active, not recruiting
Conditions
Communication
Interventions
Behavioral: Communication skills training for nurses
First Posted Date
2023-01-26
Last Posted Date
2024-08-01
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
207
Registration Number
NCT05700929
Locations
🇩🇪

University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Phase 3
Terminated
Conditions
Multiple Myeloma
Interventions
Drug: Allogeneic Stem Cells
Drug: carfilzomib/lenalidomide/dexamethasone (KRD)
Drug: elotuzumab/lenalidomide/dexamethasone (ERD)
Drug: daratumumab/bortezomib/dexamethasone (DVD)
Drug: daratumumab/lenalidomide/dexamethasone (DRD)
Drug: ixazomib/lenalidomide/dexamethasone (IRD)
Drug: pomalidomide/bortezomib/dexamethasone (PVD)
Drug: carfilzomib/daratumumab/dexamethasone (KDD)
Drug: daratumumab/pomalidomide/dexamethasone (DPD)
Drug: isatuximab/carfilzomib/dexamethasone (Isa-KD)
Drug: selinexor/bortezomib/dexamethasone (SVD)
First Posted Date
2023-01-09
Last Posted Date
2025-04-22
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Target Recruit Count
28
Registration Number
NCT05675319
Locations
🇩🇪

University Hospital of Freiburg, Freiburg, Baden-Württemberg, Germany

🇩🇪

University Hospital Tübingen, Tübingen, Baden-Württemberg, Germany

🇩🇪

Hospital North Nürnberg, Nürnberg, Bayern, Germany

and more 27 locations
© Copyright 2025. All Rights Reserved by MedPath